Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
225
-
Total 13F shares, excl. options
-
66.5M
-
Shares change
-
+1.93M
-
Total reported value, excl. options
-
$4.2B
-
Value change
-
+$137M
-
Put/Call ratio
-
2.74
-
Number of buys
-
125
-
Number of sells
-
-105
-
Price
-
$63.19
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2025
272 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q2 2025.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.5M shares
.
Largest 10 shareholders include BlackRock, Inc. (6.27M shares), BAKER BROS. ADVISORS LP (5.6M shares), RA CAPITAL MANAGEMENT, L.P. (5.56M shares), PRIMECAP MANAGEMENT CO/CA/ (4.88M shares), VANGUARD GROUP INC (3.59M shares), NEA Management Company, LLC (2.91M shares), PERCEPTIVE ADVISORS LLC (2.42M shares), FMR LLC (1.95M shares), STATE STREET CORP (1.91M shares), and GOLDMAN SACHS GROUP INC (1.73M shares).
This table shows the top 225 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.